medtech.png

MEDEOR, Truffle Capital's new BioMedTech Fund, qualified by institutional investors through the Tibi committee

The management company has just unveiled its new Fund called Truffle MEDEOR

Truffle Capital marks its ambition while wishing to respect its DNA. The management company founded by Philippe Pouletty and Bernard-Louis Roques in 2001, and directed by Patrick Kron, has just lifted the veil on its new fund, named Truffle MEDEOR. "This vehicle could total between 600 and 800 million euros, if successfully raised. It would then be the largest European Fund in the field of MedTech", Philippe Pouletty then underlined.